Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1305 for Cardioversion of Atrial Fibrillation
NCT00915356Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- May 2009
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 2 trial of AZD-1305 in Atrial fibrillation (AFib), sponsored by AstraZeneca. Started May 2009; status: completed.
02
Drugs
AZD-1305
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00915356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915356.